About
The Pegasus Therapeutics Bioresorbable Flow Diverter is being designed to treat aneurysms non-surgically and then completely dissolve away after the therapeutic timeframe. Ultimately, it's about helping young patients live longer, healthier, more productive lives. We are currently raising $50,000 to build a benchtop flow model of the heart with simulated aneurysms so that we can learn, tweak, and refine the design until it works as well as or better than its metal counterparts.
Technologies
Outlook
Amazon AWS
Remote
IoT
Company Information
-
Employees 1
-
Annual Revenue $6843000
Location
Bozeman, Montana, United States
